Accedi

Bibliografie tematiche / Cyclophosphamide

Letteratura scientifica selezionata sul tema "Cyclophosphamide"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 21 febbraio 2023

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Indice

Articoli di riviste
Tesi
Libri
Capitoli di libri
Atti di convegni
Rapporti di organizzazioni

Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Cyclophosphamide".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Articoli di riviste sul tema "Cyclophosphamide"

1

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide". Reactions Weekly &NA;, n. 369 (settembre 1991): 7. http://dx.doi.org/10.2165/00128415-199103690-00025.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide". Reactions Weekly &NA;, n. 375 (novembre 1991): 6. http://dx.doi.org/10.2165/00128415-199103750-00027.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

&NA;. "Cyclophosphamide see Carboplatin/cyclophosphamide". Reactions Weekly &NA;, n. 380 (dicembre 1991): 4. http://dx.doi.org/10.2165/00128415-199103800-00015.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

&NA;. "Cyclophosphamide see Indomethacin/cyclophosphamide". Reactions Weekly &NA;, n. 283 (gennaio 1990): 4. http://dx.doi.org/10.2165/00128415-199002830-00011.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide". Reactions Weekly &NA;, n. 324 (ottobre 1990): 4. http://dx.doi.org/10.2165/00128415-199003240-00014.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

&NA;. "Cyclophosphamide see Prednisone/cyclophosphamide". Reactions Weekly &NA;, n. 343 (marzo 1991): 4. http://dx.doi.org/10.2165/00128415-199103430-00018.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

&NA;. "Cyclophosphamide see Busulfan/cyclophosphamide". Reactions Weekly &NA;, n. 358 (luglio 1991): 7. http://dx.doi.org/10.2165/00128415-199103580-00028.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

&NA;. "Cyclophosphamide see Chlorambucil/cyclophosphamide/methotrexate". Reactions Weekly &NA;, n. 348 (aprile 1991): 7. http://dx.doi.org/10.2165/00128415-199103480-00024.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

&NA;. "Cyclophosphamide". Reactions Weekly &NA;, n. 1380 (dicembre 2011): 15. http://dx.doi.org/10.2165/00128415-201113800-00053.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

&NA;. "Cyclophosphamide". Reactions Weekly &NA;, n. 1384 (gennaio 2012): 21. http://dx.doi.org/10.2165/00128415-201213840-00081.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Più fonti

Tesi sul tema "Cyclophosphamide"

1

Levy, Karine. "Toxicité du cyclophosphamide". Paris 5, 1993. http://www.theses.fr/1993PA05P156.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Afsharian, Parvaneh. "Optimization of cyclophosphamide therapy based on pharmacogenetics /". Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-997-1/.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Yule, S. M. "The clinical pharmacology of cyclophosphamide in children". Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.309831.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Chanellière, Christiane. "Intérêt de l'utilisation du cyclophosphamide dans le traitement des pemphigoi͏̈des bulleuses et des pemphigus". Montpellier 1, 1989. http://www.theses.fr/1989MON11064.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Belfayol-Pisanté, Laurence. "Evaluation d'un index prédictif de l'apparition des effets secondaires liés au traitement par le cyclophosphamide chez des patients atteints de vascularites et de collagénoses". Paris 5, 2000. http://www.theses.fr/2000PA05P629.

Testo completo

Abstract (sommario):

Le cyclophosphamide est un agent anticancéreux et immunosuppresseur utilisé aussi bien dans le traitement des affections malignes que des maladies systémiques. Si les études pharmacocinétiques ont été largement décrites chez les patients traités par le cyclophosphamide seul ou en association pour ses propriétés antinéoplasiques, aucune n'aborde la pharmacocinétique du cyclophosphamide et de son métabolite, le 4-hydroxycyclophosphamide/aldophosphamide, chez les patients atteints de vascularites ou de collagénoses. En raison de la toxicité liée au traitement par le cyclophosphamide chez ces sujets à risque, notamment en termes d'infections, nous avons étudié s'il existait une relation entre les paramètres pharmacocinétiques et la survenue des effets indésirables. Les résultats ont montré que les paramètres pharmacocinétiques du cyclophosphamide et de son métabolite sont comparables à ceux retrouvés chez le patient cancéreux. Cependant la variabilité inter-individuelle est plus importante dans notre étude [. . . ]
Cyclophosphamide is an alkylating agent widely used for the treatment of malignant dis eases. It also has been used to treat systemic vasculitides. This immunosuppressive therapy, given in association with corticosteroids, has markedly improved the prognosis of these diseases. Although the pharmacokinetics of cyclophosphamide in cancer patients have been well documented, no information has been reported on cyclophosphamide pharmacokinetics in patients with systemic vasculitis and connectivitis. The aim of this study was to evaluate the concentrations and pharmacokinetic parameters of cyclophosphamide and its key circulating intermediate metabolite, 4-hydroxycyclophosphamide/aldophosphamide, in these patients and to define a relationships between pharmacokinetic parameters and toxic effects. The results are consistent with those obtained for cancer patients, in spite of a wide inter-patient variability of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide concentrations in our study [. . . )

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Lo, Kwun-hang Kenny. "Effects of cyclophosphamide on ulcer in rat stomachs /". View the Table of Contents & Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30708825.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

盧冠恆 e Kwun-hang Kenny Lo. "Effects of cyclophosphamide on ulcer in rat stomachs". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B45010158.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Maynard-Faure, Patricia. "Synthèse d'analogues bicycliques préactives du cyclophosphamide et de l'aldophosphamide". Lyon 1, 1997. http://www.theses.fr/1997LYO10268.

Testo completo

Abstract (sommario):

Ce memoire de these concerne l'etude de voies de synthese de nouveaux analogues du cyclophosphamide et de l'aldophosphamide. Apres avoir rappele la place du cyclophosphamide, agent cancerostatique le plus utilise en clinique humaine, dans l'arsenal des medicaments anticancereux, nous avons passe en revue les nombreux analogues deja synthetises en vue d'obtenir des composes a index therapeutique plus eleve. Nous presentons ensuite des voies de syntheses possibles pour des derives bicycliques preactives cibles ne necessitant pas d'activation biologique. Ce travail a permis de completer l'etude des voies d'acces au 3-n,n-bis (2-chloroethyl) amino -3-oxo-2-aza-4,9-dioxa-3-phosphabicyclo- (4, 3, 0) nonane precedemment synthetise, mais aussi de preparer de nouveaux analogues spiranniques en serie furanique et pyranique. Il a ete largement etendu en serie sucre par la preparation de composes du meme type derives du d-arabinose et du d-glucose. Ces preparations ont ete l'occasion de mettre au point de nouvelles methodologies, concernant notamment la synthese apres allongement de chaine d'azidoalcools originaux derives de l'arabinose et la n-glycosylation intramoleculaire de phosphoramides. La determination de la structure des nouveaux composes a necessite une analyse approfondie au moyen des techniques de resonance magnetique nucleaire les plus recentes, apportant par la-meme de nouvelles informations sur les facteurs influencant la geometrie des heterocycles du type oxazaphosphorinane. L'existence de conformations non chaises semble etre ainsi la regle pour des structures steriquement contraintes.

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Lu, Hong. "Pharmacokinetic and drug metabolism studies of cyclophosphamide and ifosfamide /". The Ohio State University, 1998. http://rave.ohiolink.edu/etdc/view?acc_num=osu148795015360318.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Li, Zhaoyang. "DNA alkylation by active metabolites of Cyclophosphamide and Ifosfamide /". The Ohio State University, 1999. http://rave.ohiolink.edu/etdc/view?acc_num=osu1488192960169091.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Più fonti

Libri sul tema "Cyclophosphamide"

1

Boche, Gernot. Cyclopropane derived reactive intermediates. Chichester: Wiley, 1990.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Asli-Yalfani, Esmael. Cellular and molecular studies of the immunopharmacology of cyclophosphamide. Manchester: University of Manchester, 1995.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Azria, M. (Moïse). Calcitonins: Physiological and pharmacological aspects. Berlin: Springer Verlag, 1989.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Lewtas, Joellen. Final report on the evaluation of four toxic chemicals in an In Vivo/In Vitro toxicological screen--acrylamide, chlordecone, cyclophosphamide, and diethylstilbestrol. Research Triangle Park, N.C: U.S. Environmental Protection Agency, Health Effects Research Laboratory, 1986.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Blokdijk, G. J. Cyclophosphamide; The Ultimate Step-By-Step Guide. CreateSpace Independent Publishing Platform, 2018.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

R, Nowrousian M., a cura di. Ifosfamide in cancer therapy: A comparison with cyclophosphamide. Jena: Universitätsverlag, 1993.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Cyclophosphamide: Clinical Pharmacology, Uses and Potential Adverse Effects. Nova Science Publishers, Incorporated, 2015.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Publications, ICON Health. Cyclophosphamide - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Chen, Chu-liang. Identification of an inguinal adipocyte-specific protein using monoclonal antibody selected by cyclophosphamide. 1992.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Progress in Clinical Biochemistry and Medicine. Springer Verlag, 1989.

Cerca il testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Più fonti

Capitoli di libri sul tema "Cyclophosphamide"

1

Maxwell, Robert A., e Shohreh B. Eckhardt. "Cyclophosphamide". In Drug Discovery, 265–80. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-0469-5_20.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Mader, Ines, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz e Sabine Wassertheurer. "Cyclophosphamide". In Extravasation of Cytotoxic Agents, 155–59. Vienna: Springer Vienna, 2010. http://dx.doi.org/10.1007/978-3-211-88893-3_22.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Schwab, Manfred. "Cyclophosphamide". In Encyclopedia of Cancer, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_1439-2.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Bartlett, R. R. "Cyclophosphamide". In Handbook of Experimental Pharmacology, 453–69. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73217-1_20.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Scorer, Matthew, Olga Golberg e Karen Harman. "Cyclophosphamide". In Handbook of Systemic Drug Treatment in Dermatology, 112–19. 3^a ed. London: CRC Press, 2022. http://dx.doi.org/10.1201/9781003016786-16.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Curtis, John J. "Cyclophosphamide". In Immunotherapy in Transplantation, 290–95. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781444355628.ch19.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Mader, Ines, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola e Sabine M. Wassertheurer. "Cyclophosphamide". In Extravasation of Cytotoxic Agents, 92–94. Vienna: Springer Vienna, 2003. http://dx.doi.org/10.1007/978-3-7091-3710-9_15.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

de Groot, Anton C. "Cyclophosphamide". In Monographs In Contact Allergy, 342. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003158004-160.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Neumann, Ron. "Cyclophosphamide". In Intraocular Inflammation, 323–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-540-75387-2_24.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Saxena, Ajit Kumar, e Amit Kumar. "Introduction of Cyclophosphamide". In Fish Analysis for Drug and Chemicals Mediated Cellular Toxicity, 1–5. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-4700-3_1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Atti di convegni sul tema "Cyclophosphamide"

1

Kobrová, Kateřina, Lenka Minxová, Jakub Zieg, Sylva Skálová e Pavla Doležalová. "AB0998 SEVERE IGA VASCULITIS: CYCLOPHOSPHAMIDE IN QUESTION". In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.6731.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Ertenli, Ý., V. Cobankara, S. Apras, S. Kiraz, MA Oztürk e M. Çalgüneri. "AB0079 Cyclophosphamide exposure during pregnancy: two cases". In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.124.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

VIEIRA, ADAH SOPHIA RODRIGUES, GUILHERME LOPES PEREIRA, ANTÔNIO JOSÉ DA SILVA NETO, ALINE DE CASTRO CARACAS, RODRIGO BARBOSA DE AZEVEDO e REJANE MARIA RODRIGUES DE ABREU VIEIRA. "RITUXIMAB IN POLYARTERITIS CYCLOPHOSPHAMIDE INTOLERANT NODOSE: CASE REPORT". In 36º Congresso Brasileiro de Reumatologia. São Paulo: Editora Blucher, 2019. http://dx.doi.org/10.5151/sbr2019-231.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Tanaka, N., A. Hirano, H. Inoue, K. Ogura, A. Hattori, N. Jibiki, H. Yukawa et al. "Abstract OT1-01-02: A phase II trial of neoadjuvant docetaxel/cyclophosphamide followed by epirubicin/cyclophosphamide for triple-negative breast cancer". In Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.sabcs16-ot1-01-02.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Constantin, Mirela Alina, Lucian Alexandru Constantin, Nicolae Ionut Cristea e Ines Nitoi. "INFLUENCE OF TiO2 DOPANT TYPE UPON CYCLOPHOSPHAMIDE DEGRADATION EFFICIENCY". In International Symposium "The Environment and the Industry". National Research and Development Institute for Industrial Ecology, 2017. http://dx.doi.org/10.21698/simi.2017.0003.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Son, R., D. Hwang, AH Jung, JM Lim, SH Jung, SY Suh, HJ Hahn, YS Cho, EJ Park e HI Cheong. "5PSQ-082 Cyclophosphamide therapy in children with nephrotic syndrome". In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.436.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Chalwadi, U. K., M. Pertzborn, N. Swamy e A. Agarwal. "Cyclophosphamide-Induced Late Onset Pulmonary Fibrosis in Pediatric Patient". In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3263.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Kong, Chia Wei, Oluwatobi Adeagbo, Robert Hooper, Vanessa Titmuss e Suresh Babu. "Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD)". In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2982.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Yamauchi, Kensuke, Meng Yang, Katsuhiro Hayashi, Ping Jiang, Mingxu Xu, Norio Yamamoto, Hiroyuki Tsuchiya et al. "Imaging enhancement of malignancy by cyclophosphamide: surprising chemotherapy opposite effects". In Biomedical Optics (BiOS) 2008, a cura di Alexander P. Savitsky, Robert E. Campbell e Robert M. Hoffman. SPIE, 2008. http://dx.doi.org/10.1117/12.772085.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Daillere, Romain, Marie Vetizou e Laurence Zitvogel. "Abstract 4928: Impact ofE. hiraeon the tumoricidal activity of cyclophosphamide". In Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC. American Association for Cancer Research, 2017. http://dx.doi.org/10.1158/1538-7445.am2017-4928.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Rapporti di organizzazioni sul tema "Cyclophosphamide"

1

Lao, Lixing, e Richard H. Wong. The Effect of Electroacupuncture on Cyclophosphamide-Induced Emesis in Ferrets. Fort Belvoir, VA: Defense Technical Information Center, luglio 1995. http://dx.doi.org/10.21236/ada299200.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Yin, Xietian, Shichao Zhao, Nan Xiang, Jidong Chen, Jun Xu e Yudan Zhang. Efficacy and Safety of Chinese Herbal Medicines combined with Cyclophosphamide for Connective Tissue Disease-Associated Interstitial Lung Disease: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, dicembre 2022. http://dx.doi.org/10.37766/inplasy2022.12.0010.

Testo completo

Abstract (sommario):

Review question / Objective: To evaluate the effectiveness and safety of Chinese herbal medicines (CHMs) combined with cyclophosphamide (CTX) for connective tissue disease-associated interstitial lung disease (CTD-ILD) by performing a meta-analysis. Condition being studied: Chinese herbal medicines (CHMs) and cyclophosphamide (CTX) are widely used in the treatment of connective tissue disease-associated interstitial lung disease (CTD-ILD). However, the clinical benefits of CHMs treatment for CTD-ILD are still controversial, and there is no systemic review to summarize and evaluate their efficacy and safety.

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Zhang, LiBo, GuangZhen Liu e YanChuang Liang. Meta analysis of traditional Chinese medicine combined with cyclophosphamide in the treatment of adult refractory nephrotic syndrome. International Platform of Registered Systematic Review and Meta-analysis Protocols, maggio 2020. http://dx.doi.org/10.37766/inplasy2020.5.0020.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Emens, Leisha A., e Elizabeth M. Jaffee. Enhancement of an Allogeneic GM-CSF-Secreting Breast Cancer Vaccine by Immunomodulatory Doses of Cyclophosphamide and Doxorubicin. Fort Belvoir, VA: Defense Technical Information Center, giugno 2003. http://dx.doi.org/10.21236/ada417167.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!